IRCT20260623069929N1 IRCT 2026-07-10 Vice Chancellor for Research, Islamic Azad University, Najafabad Branch Fenelis herbal product for hot flashes in menopausal women Comparison of Hot Flash Severity, Frequency, and Duration Before and After Administration of Fenelis Herbal Product in Menopausal Women 2020-03-20 anticipated 20 Complete https://irct.ir/trial/91118 interventional Randomization: N/A, Blinding: Triple blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment, Blinding description: This study was designed as a triple-blind clinical trial. Participants were unaware of the exact composition and anticipated effects of the Fenelis formulation to minimize performance bias. The healthcare personnel responsible for administering the capsules were blinded to the study hypotheses and expected outcomes. Outcome assessors who evaluated the severity, frequency, and duration of hot flashes, as well as the quality of life, anxiety, and depression questionnaires, were also blinded to the study objectives. Prior to statistical analysis, all data were coded, and the data analyst worked exclusively with the coded dataset. 2 Menopausal hot flashes (vasomotor symptoms associated with menopause). Intervention group: Participants assigned to the intervention group received Fenelis herbal capsules. Fenelis is a combined phytoestrogenic herbal formulation containing Melissa officinalis (lemon balm), Foeniculum vulgare (fennel), and Golghand (rose petal preserve), developed according to the principles of Traditional Persian Medicine. Following a one-week baseline symptom recording period, participants orally consumed the capsules for three consecutive weeks.. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The decision on sharing deidentified individual participant data has not yet been finalized. A final decision will be made following completion of the manuscript review and publication process.